Barely Significant
← all excerpts

A Novel GLP-1 and FGF21 Fusion Protein for the Treatment of Non-alcoholic Steatohepatitis (NASH).

Adv Pharm Bull · 2025 · PMC12235361 · PMID 40636296

1
hedged sentence
closest p
boldest claim

The sentences

Based on the fibrosis scoring results, HSP763-01 showed a slight reduction in fibrosis score, although it did not reach statistical significance and was less effective in alleviating liver fibrosis compared to the positive control OCA.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.